These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 7150357

  • 21. Structure of amplified DNA in different Syrian hamster cell lines resistant to N-(phosphonacetyl)-L-aspartate.
    Ardeshir F, Giulotto E, Zieg J, Brison O, Liao WS, Stark GR.
    Mol Cell Biol; 1983 Nov; 3(11):2076-88. PubMed ID: 6656763
    [Abstract] [Full Text] [Related]

  • 22. Effect of high-protein diet on pyrimidine synthesis and response to PALA in mouse tissues.
    Zaharevitz DW, Grubb MF, Hyman R, Chisena C, Cysyk RL.
    J Natl Cancer Inst; 1993 Apr 21; 85(8):662-6. PubMed ID: 8468725
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Phosphorylation and dephosphorylation of carbamoyl-phosphate synthetase II complex of rat ascites hepatoma cells.
    Otsuki T, Mori M, Tatibana M.
    J Biochem; 1981 May 21; 89(5):1367-74. PubMed ID: 6115855
    [Abstract] [Full Text] [Related]

  • 29. Overexpression of the 18 kDa and 22/24 kDa FGF-2 isoforms results in differential drug resistance and amplification potential.
    Dini G, Funghini S, Witort E, Magnelli L, Fanti E, Rifkin DB, Del Rosso M.
    J Cell Physiol; 2002 Oct 21; 193(1):64-72. PubMed ID: 12209881
    [Abstract] [Full Text] [Related]

  • 30. Binding of radiolabeled N-(phosphonacetyl)-L-aspartate to aspartate transcarbamylase from Ehrlich ascites tumor cells.
    White JC, Hines LH.
    Biochem Pharmacol; 1984 Nov 15; 33(22):3645-8. PubMed ID: 6508821
    [Abstract] [Full Text] [Related]

  • 31. Pharmacological and biochemical interactions of N-(phosphonacetyl)-L-aspartate and 5-fluorouracil in beagles.
    Miller AA, Moore EC, Hurlbert RB, Benvenuto JA, Loo TL.
    Cancer Res; 1983 Jun 15; 43(6):2565-70. PubMed ID: 6189583
    [Abstract] [Full Text] [Related]

  • 32. Kinetic parameters of aspartate transcarbamylase in human normal and tumoral cell lines.
    Baillon J, Guichard M, Malaise EP, Hervé G.
    Cancer Res; 1983 May 15; 43(5):2277-82. PubMed ID: 6831451
    [Abstract] [Full Text] [Related]

  • 33. Late onset of CAD gene amplification in unamplified PALA resistant Chinese hamster mutants.
    Mucciolo E, Bertoni L, Mondello C, Giulotto E.
    Cancer Lett; 2000 Mar 31; 150(2):119-27. PubMed ID: 10704733
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Pharmacological disposition of N-(phosphonacetyl)-L-aspartate in humans.
    Loo TL, Friedman J, Moore EC, Valdivieso M, Marti JR, Stewart D.
    Cancer Res; 1980 Jan 31; 40(1):86-90. PubMed ID: 7349907
    [Abstract] [Full Text] [Related]

  • 36. Kinetics of N-(phosphonacetyl)-L-aspartate and pyrazofurin depletion of pyrimidine ribonucleotide and deoxyribonucleotide pools and their relationship to nucleic acid synthesis in intact and permeabilized cells.
    Moyer JD, Smith PA, Levy EJ, Handschumacher RE.
    Cancer Res; 1982 Nov 31; 42(11):4525-31. PubMed ID: 7127293
    [Abstract] [Full Text] [Related]

  • 37. Effect of N-(phosphonacetyl)-L-aspartate on 5-azacytidine metabolism in P388 and L1210 cells.
    Grant S, Rauscher F, Jakubowski A, Cadman E.
    Cancer Res; 1981 Feb 31; 41(2):410-8. PubMed ID: 6160908
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Selective inhibition of pyrimidine synthesis and depletion of nucleotide pools by N-(phosphonacetyl)-L-aspartate.
    Moyer JD, Handschumacher RE.
    Cancer Res; 1979 Aug 31; 39(8):3089-94. PubMed ID: 455293
    [No Abstract] [Full Text] [Related]

  • 40. A 70-amino acid zinc-binding polypeptide fragment from the regulatory chain of aspartate transcarbamoylase causes marked changes in the kinetic mechanism of the catalytic trimer.
    Zhou BB, Waldrop GL, Lum L, Schachman HK.
    Protein Sci; 1994 Jun 31; 3(6):967-74. PubMed ID: 8069226
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.